Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Y Gulenchyn

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Medical Imaging and Radiation Sciences|May 5, 2019
Is Thyroid Screening Necessary for Nuclear Medicine Personnel Receiving and Administering Capsules Containing Large Doses of <sup>131</sup>I?Karen Y Gulenchyn, Colin E Webber
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2008
Is there a role for positron emission tomography in breast cancer staging?Nicole C Hodgson, Karen Y Gulenchyn
Radiation Protection Dosimetry|July 11, 2006
Radiation exposure for 'caregivers' during high-dose outpatient radioiodine therapyChristopher J Marriott, Colin E Webber, Karen Y Gulenchyn
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|February 23, 2010
Is a fixed value for the least significant change appropriate?Lisa Nelson, Karen Y Gulenchyn, Mark Atthey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Evidence-based approach to the introduction of positron emission tomography in ontario, CanadaWilliam K Evans, Andreas Laupacis, Karen Y Gulenchyn, et al.
Nuclear Medicine Communications|December 21, 2011
PET/CT using ¹⁸F-FDOPA provides improved staging of carcinoid tumor patients in a Canadian settingValerie N Yakemchuk, Pieter L Jager, Raman Chirakal, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|February 25, 2011
Radiation doses originating from diagnostic procedures during the treatment and follow-up of children and adolescents with malignant lymphomaJessica Pierobon, Colin E Webber, Trishana Nayiager, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2008
6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applicationsPieter L Jager, Raman Chirakal, Christopher J Marriott, et al.
Biomarkers in Cancer|March 8, 2016
Imaging Biomarkers in ImmunotherapyRosalyn A Juergens, Katherine A Zukotynski, Amit Singnurkar, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|March 5, 2010
Combined vertebral fracture assessment and bone mineral density measurement: a patient-friendly new tool with an important impact on the Canadian Risk Fracture ClassificationPieter L Jager, Riemer H J A Slart, Colin L Webber, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Medical Imaging and Radiation Sciences|May 5, 2019
Is Thyroid Screening Necessary for Nuclear Medicine Personnel Receiving and Administering Capsules Containing Large Doses of <sup>131</sup>I?Karen Y Gulenchyn, Colin E Webber
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2008
Is there a role for positron emission tomography in breast cancer staging?Nicole C Hodgson, Karen Y Gulenchyn
Radiation Protection Dosimetry|July 11, 2006
Radiation exposure for 'caregivers' during high-dose outpatient radioiodine therapyChristopher J Marriott, Colin E Webber, Karen Y Gulenchyn
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|February 23, 2010
Is a fixed value for the least significant change appropriate?Lisa Nelson, Karen Y Gulenchyn, Mark Atthey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Evidence-based approach to the introduction of positron emission tomography in ontario, CanadaWilliam K Evans, Andreas Laupacis, Karen Y Gulenchyn, et al.
Nuclear Medicine Communications|December 21, 2011
PET/CT using ¹⁸F-FDOPA provides improved staging of carcinoid tumor patients in a Canadian settingValerie N Yakemchuk, Pieter L Jager, Raman Chirakal, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|February 25, 2011
Radiation doses originating from diagnostic procedures during the treatment and follow-up of children and adolescents with malignant lymphomaJessica Pierobon, Colin E Webber, Trishana Nayiager, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2008
6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applicationsPieter L Jager, Raman Chirakal, Christopher J Marriott, et al.
Biomarkers in Cancer|March 8, 2016
Imaging Biomarkers in ImmunotherapyRosalyn A Juergens, Katherine A Zukotynski, Amit Singnurkar, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|March 5, 2010
Combined vertebral fracture assessment and bone mineral density measurement: a patient-friendly new tool with an important impact on the Canadian Risk Fracture ClassificationPieter L Jager, Riemer H J A Slart, Colin L Webber, et al.
Pageof 2